Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from FDA
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase
Take a look at what other researchers and scientists are saying about cutting-edge technologies in engineered antibodies
Explore our exclusive interviews, free downloads, latest methods, and much more to help support your antibody research
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new product which has made the most difference to your research
The monthly safety report will be made public on the European Medicines Agency website
Dr. Christian Frisch explains how to design a reliable assay and reveals how Bio-Rad and Sartorius teamed up to help scientists achieve peak immunoassay performance
Top talks presenting the latest technologies, research and applications are now available on demand
Discovery is a result of Abbott's continued virus hunting efforts, which also uncovered a new strain of HIV in 2019
International experts are joining forces to combat vaccine hesitancy by tackling its root cause
Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine
Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
Explore topics from therapeutic antibodies and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing
The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination
Explore topics from oligonucleotides and high-sensitivity troponin assays to therapeutic antibodies and advances in COVID-19 sample prep